218 related articles for article (PubMed ID: 33545384)
1. Effect of liver total sphingomyelin synthase deficiency on plasma lipid metabolism.
Li Z; Chiang YP; He M; Zhang K; Zheng J; Wu W; Cai J; Chen Y; Chen G; Chen Y; Dong J; Worgall TS; Jiang XC
Biochim Biophys Acta Mol Cell Biol Lipids; 2021 May; 1866(5):158898. PubMed ID: 33545384
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of sphingomyelin synthase (SMS) affects intracellular sphingomyelin accumulation and plasma membrane lipid organization.
Li Z; Hailemariam TK; Zhou H; Li Y; Duckworth DC; Peake DA; Zhang Y; Kuo MS; Cao G; Jiang XC
Biochim Biophys Acta; 2007 Sep; 1771(9):1186-94. PubMed ID: 17616479
[TBL] [Abstract][Full Text] [Related]
3. Effect of Total SMS Activity on LDL Catabolism in Mice.
Li Z; He M; Chen G; Souaiaia T; Worgall TS; Jiang XC
Arterioscler Thromb Vasc Biol; 2023 Jul; 43(7):1251-1261. PubMed ID: 37128925
[TBL] [Abstract][Full Text] [Related]
4. Sphingomyelin synthase 2 is one of the determinants for plasma and liver sphingomyelin levels in mice.
Liu J; Zhang H; Li Z; Hailemariam TK; Chakraborty M; Jiang K; Qiu D; Bui HH; Peake DA; Kuo MS; Wadgaonkar R; Cao G; Jiang XC
Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):850-6. PubMed ID: 19286635
[TBL] [Abstract][Full Text] [Related]
5. Impact of sphingomyelin synthase 1 deficiency on sphingolipid metabolism and atherosclerosis in mice.
Li Z; Fan Y; Liu J; Li Y; Huan C; Bui HH; Kuo MS; Park TS; Cao G; Jiang XC
Arterioscler Thromb Vasc Biol; 2012 Jul; 32(7):1577-84. PubMed ID: 22580896
[TBL] [Abstract][Full Text] [Related]
6. Adenovirus-mediated overexpression of sphingomyelin synthases 1 and 2 increases the atherogenic potential in mice.
Dong J; Liu J; Lou B; Li Z; Ye X; Wu M; Jiang XC
J Lipid Res; 2006 Jun; 47(6):1307-14. PubMed ID: 16508036
[TBL] [Abstract][Full Text] [Related]
7. Deficiency of sphingomyelin synthase 1 but not sphingomyelin synthase 2 reduces bone formation due to impaired osteoblast differentiation.
Matsumoto G; Hashizume C; Watanabe K; Taniguchi M; Okazaki T
Mol Med; 2019 Dec; 25(1):56. PubMed ID: 31847800
[TBL] [Abstract][Full Text] [Related]
8. All members in the sphingomyelin synthase gene family have ceramide phosphoethanolamine synthase activity.
Ding T; Kabir I; Li Y; Lou C; Yazdanyar A; Xu J; Dong J; Zhou H; Park T; Boutjdir M; Li Z; Jiang XC
J Lipid Res; 2015 Mar; 56(3):537-545. PubMed ID: 25605874
[TBL] [Abstract][Full Text] [Related]
9. Sphingomyelin synthase 2 activity and liver steatosis: an effect of ceramide-mediated peroxisome proliferator-activated receptor γ2 suppression.
Li Y; Dong J; Ding T; Kuo MS; Cao G; Jiang XC; Li Z
Arterioscler Thromb Vasc Biol; 2013 Jul; 33(7):1513-20. PubMed ID: 23640498
[TBL] [Abstract][Full Text] [Related]
10. Effect of Total Sphingomyelin Synthase Activity on Low Density Lipoprotein Catabolism in Mice.
Li Z; He M; Chen G; Worgall TS; Jiang XC
bioRxiv; 2023 Feb; ():. PubMed ID: 36798262
[TBL] [Abstract][Full Text] [Related]
11. SMS overexpression and knockdown: impact on cellular sphingomyelin and diacylglycerol metabolism, and cell apoptosis.
Ding T; Li Z; Hailemariam T; Mukherjee S; Maxfield FR; Wu MP; Jiang XC
J Lipid Res; 2008 Feb; 49(2):376-85. PubMed ID: 17982138
[TBL] [Abstract][Full Text] [Related]
12. Sphingomyelin synthases 1 and 2 exhibit phosphatidylcholine phospholipase C activity.
Chiang YP; Li Z; Chen Y; Cao Y; Jiang XC
J Biol Chem; 2021 Dec; 297(6):101398. PubMed ID: 34774525
[TBL] [Abstract][Full Text] [Related]
13. Development of a quantitative biochemical and cellular sphingomyelin synthase assay using mass spectrometry.
Chen Y; Yurek DA; Yu L; Wang H; Ehsani ME; Qian YW; Konrad RJ; Jiang XC; Kuo MS; Cao G; Wang J
Anal Biochem; 2013 Jul; 438(1):61-6. PubMed ID: 23535273
[TBL] [Abstract][Full Text] [Related]
14. Adenovirus-mediated sphingomyelin synthase 2 increases atherosclerotic lesions in ApoE KO mice.
Wang X; Dong J; Zhao Y; Li Y; Wu M
Lipids Health Dis; 2011 Jan; 10():7. PubMed ID: 21235823
[TBL] [Abstract][Full Text] [Related]
15. Macrophage sphingomyelin synthase 2 deficiency decreases atherosclerosis in mice.
Liu J; Huan C; Chakraborty M; Zhang H; Lu D; Kuo MS; Cao G; Jiang XC
Circ Res; 2009 Jul; 105(3):295-303. PubMed ID: 19590047
[TBL] [Abstract][Full Text] [Related]
16. Both sphingomyelin synthases SMS1 and SMS2 are required for sphingomyelin homeostasis and growth in human HeLa cells.
Tafesse FG; Huitema K; Hermansson M; van der Poel S; van den Dikkenberg J; Uphoff A; Somerharju P; Holthuis JC
J Biol Chem; 2007 Jun; 282(24):17537-47. PubMed ID: 17449912
[TBL] [Abstract][Full Text] [Related]
17. Subcellular targeting domains of sphingomyelin synthase 1 and 2.
Yeang C; Ding T; Chirico WJ; Jiang XC
Nutr Metab (Lond); 2011 Dec; 8():89. PubMed ID: 22168400
[TBL] [Abstract][Full Text] [Related]
18. Dynamic modification of sphingomyelin in lipid microdomains controls development of obesity, fatty liver, and type 2 diabetes.
Mitsutake S; Zama K; Yokota H; Yoshida T; Tanaka M; Mitsui M; Ikawa M; Okabe M; Tanaka Y; Yamashita T; Takemoto H; Okazaki T; Watanabe K; Igarashi Y
J Biol Chem; 2011 Aug; 286(32):28544-55. PubMed ID: 21669879
[TBL] [Abstract][Full Text] [Related]
19. Sphingomyelin synthase 1 mediates hepatocyte pyroptosis to trigger non-alcoholic steatohepatitis.
Koh EH; Yoon JE; Ko MS; Leem J; Yun JY; Hong CH; Cho YK; Lee SE; Jang JE; Baek JY; Yoo HJ; Kim SJ; Sung CO; Lim JS; Jeong WI; Back SH; Baek IJ; Torres S; Solsona-Vilarrasa E; Conde de la Rosa L; Garcia-Ruiz C; Feldstein AE; Fernandez-Checa JC; Lee KU
Gut; 2021 Oct; 70(10):1954-1964. PubMed ID: 33208407
[TBL] [Abstract][Full Text] [Related]
20. Deficiency of sphingomyelin synthase-1 but not sphingomyelin synthase-2 causes hearing impairments in mice.
Lu MH; Takemoto M; Watanabe K; Luo H; Nishimura M; Yano M; Tomimoto H; Okazaki T; Oike Y; Song WJ
J Physiol; 2012 Aug; 590(16):4029-44. PubMed ID: 22641779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
